Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-20-000337
Filing Date
2020-02-14
Accepted
2020-02-14 16:10:46
Documents
1
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form5-02142020_010232.html 5  
1 form5-02142020_010232.xml 5 5590
  Complete submission text file 0001415889-20-000337.txt   7039
Mailing Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024
Business Address 10900 WILSHIRE BLVD SUITE 600 LOS ANGELES CA 90024 310-388-6706
ChromaDex Corp. (Issuer) CIK: 0001386570 (see all company filings)

EIN.: 262940963 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address 100 NORTH CRESCENT DRIVE BEVERLY HILLS CA 90210
Business Address
Fried Robert N (Reporting) CIK: 0001417952 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-37752 | Film No.: 20619767